Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus

INTRODUCTION: The safety and efficacy of pembrolizumab administration in patients with urothelial carcinoma and underlying autoimmune disease (including overlap syndrome) is unknown. CASE PRESENTATION: We present the case of a 67‐year‐old woman with cT3N2M0 metastatic renal pelvic cancer who had bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurokawa, Masayuki, Naito, Sei, Ito, Suguru, Takai, Satoshi, Kawamura, Yuko, Kaneko, Hisashi, Kakizaki, Hiroshi, Tsuchiya, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469821/
https://www.ncbi.nlm.nih.gov/pubmed/32914068
http://dx.doi.org/10.1002/iju5.12175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469821/
https://www.ncbi.nlm.nih.gov/pubmed/32914068
http://dx.doi.org/10.1002/iju5.12175

Ejemplares similares